Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study


Akgun Z., Saglam S., YÜCEL S., Gural Z., Balik E., Cipe G., ...More

CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.74, no.4, pp.751-756, 2014 (SCI-Expanded) identifier identifier identifier

Abstract

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.